ProteinLogic attended the 48th Union World Conference on Lung Health held in Guadalajara, Mexico, held on 11th-14th October 2017. The conference theme was ‘Accelerating Toward Elimination’.
There was a focus on how to accelerate toward elimination of Tuberculosis. Numerous prominent scientists and global thought leaders emphasised the need for pro-active steps to find people with Active TB and the importance of blood based rule-out triage test for Active TB.
Delegates from more than 100 countries attended the four-day scientific programme of plenaries, symposia and abstracts presented by experts from around the world. The conference saw debate and discussion from public health professionals, researchers, scientists, civil society and the community.
Further information:
Mahesh Shah, ProteinLogic Ltd,
mahesh.shah@proteinlogic.com
ProteinLogic
ProteinLogic is a biomarker discovery and exploitation company developing a novel diagnostic platform and diagnostic products that address key unmet medical needs in infection and inflammatory diseases. The Company has developed a proprietary biomarker technology (ImmiPrint®) with potential to diagnose and predict early onset of diseases, and to provide information as to how a disease is likely to develop and respond to particular drug treatments. The technology is based upon the profiling of a discrete subset of immune system proteins found in the blood and other body fluids.
In addition to the TB diagnostic test there are a number of potential follow-on products in the Company’s pipeline.
www.proteinlogic.com